Hunt BG - Search Results

1

Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.

Wicker CA, Hunt BG, Krishnan S, Aziz K, Parajuli S, Palackdharry S, Elaban WR, Wise-Draper TM, Mills GB, Waltz SE, Takiar V. Wicker CA, et al. Among authors: hunt bg. Cancer Lett. 2021 Apr 1;502:180-188. doi: 10.1016/j.canlet.2020.12.038. Epub 2021 Jan 12. Cancer Lett. 2021. PMID: 33450358 Free PMC article.

2

Maternal diethylhexyl phthalate exposure affects adiposity and insulin tolerance in offspring in a PCNA-dependent manner.

Hunt BG, Wang YL, Chen MS, Wang SC, Waltz SE. Hunt BG, et al. Environ Res. 2017 Nov;159:588-594. doi: 10.1016/j.envres.2017.09.004. Epub 2017 Sep 12. Environ Res. 2017. PMID: 28915506 Free PMC article.

3

MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.

Hunt BG, Wicker CA, Bourn JR, Lower EE, Takiar V, Waltz SE. Hunt BG, et al. Breast Cancer Res Treat. 2020 Jun;181(3):529-540. doi: 10.1007/s10549-020-05653-y. Epub 2020 Apr 27. Breast Cancer Res Treat. 2020. PMID: 32342233 Free PMC article.

4

Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.

Bourn JR, Ruiz-Torres SJ, Hunt BG, Benight NM, Waltz SE. Bourn JR, et al. Among authors: hunt bg. Cancer Lett. 2021 Apr 10;503:75-90. doi: 10.1016/j.canlet.2021.01.019. Epub 2021 Jan 27. Cancer Lett. 2021. PMID: 33508385 Free PMC article.

5

Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35.

Ruiz-Torres SJ, Bourn JR, Benight NM, Hunt BG, Lester C, Waltz SE. Ruiz-Torres SJ, et al. Among authors: hunt bg. Oncogene. 2022 Jan;41(3):321-333. doi: 10.1038/s41388-021-02091-y. Epub 2021 Nov 6. Oncogene. 2022. PMID: 34743208 Free PMC article.

6

RON (MST1R) and HGFL (MST1) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk.

Hunt BG, Jones A, Lester C, Davis JC, Benight NM, Waltz SE. Hunt BG, et al. Cancers (Basel). 2022 May 19;14(10):2493. doi: 10.3390/cancers14102493. Cancers (Basel). 2022. PMID: 35626096 Free PMC article.

7

Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling.

Brown NE, Jones A, Hunt BG, Waltz SE. Brown NE, et al. Among authors: hunt bg. Prostate. 2022 Nov;82(15):1422-1437. doi: 10.1002/pros.24416. Epub 2022 Jul 21. Prostate. 2022. PMID: 35860905 Free PMC article.

8

NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.

Vicente-Muñoz S, Hunt BG, Lange TE, Wells SI, Waltz SE. Vicente-Muñoz S, et al. Among authors: hunt bg. PLoS One. 2022 Sep 6;17(9):e0274128. doi: 10.1371/journal.pone.0274128. eCollection 2022. PLoS One. 2022. PMID: 36067206 Free PMC article.

9

An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling.

Hunt BG, Fox LH, Davis JC, Jones A, Lu Z, Waltz SE. Hunt BG, et al. Genes (Basel). 2023 Feb 17;14(2):517. doi: 10.3390/genes14020517. Genes (Basel). 2023. PMID: 36833444 Free PMC article. Review.

10

RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence.

Hunt BG, Davis JC, Fox LH, Vicente-Muñoz S, Lester C, Wells SI, Waltz SE. Hunt BG, et al. Oncogene. 2023 May;42(21):1716-1727. doi: 10.1038/s41388-023-02688-5. Epub 2023 Apr 7. Oncogene. 2023. PMID: 37029299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters